(Q34726045)

4 August 2017

1 reference

title

Adoptive transfer of T-cell immunity (English)

1 reference

4 August 2017

3

Ton N M Schumacher

1 reference

4 August 2017

Helmut W H G Kessels

1

1 reference

4 August 2017

Monika C Wolkers

series ordinal

2

1 reference

4 August 2017

publication date

1 May 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

23

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

264-269

1 reference

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Adoptive immunotherapy prevents prostate cancer in a transgenic animal model

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Tracing and characterization of the low-avidity self-specific T cell repertoire.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Characterization of CD8+ T Lymphocytes That Persist After Peripheral Tolerance to a Self Antigen Expressed in the Pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Low avidity recognition of self-antigen by T cells permits escape from central tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

The graft-versus-leukemia effects of allogeneic cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Identical-twin bone marrow transplants for leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

In vivo tracking of tumor-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Transfer of specificity by murine alpha and beta T-cell receptor genes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Immunotherapy through TCR gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Functional expression of chimeric receptor genes in human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Self tolerance is H–2-restricted

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Evidence from in vitro studies that tolerance to self antigens is MHC-restricted

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

On the nature of peptides involved in T cell alloreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Immunotherapy with CTLs restricted by nonself MHC.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Selection of phage antibodies by binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

In vitro evolution of a T cell receptor with high affinity for peptide/MHC.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

Changing T cell specificity by retroviral T cell receptor display

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902219-6

7 January 2021

10.1016/S1471-4906(02)02219-6

Identifiers

DOI

1 reference

4 August 2017

1 reference